In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus

Nagasundaram Nagarajan, Edward K.Y. Yapp, Nguyen Quoc Khanh Le, Hui Yuan Yeh

Research output: Contribution to journalArticle

Abstract

Ebola virus is a virulent pathogen that causes highly lethal hemorrhagic fever in human and non-human species. The rapid growth of this virus infection has made the scenario increasingly complicated to control the disease. Receptor viral matrix protein (VP40) is highly responsible for the replication and budding of progeny virus. The binding of RNA to VP40 could be the crucial factor for the successful lifecycle of the Ebola virus. In this study, we aimed to identify the potential drug that could inhibit VP40. Sugar alcohols were enrich with antiviral properties used to inhibit VP40. Virtual screening analysis was perform for the 48 sugar alcohol compounds, of which the following three compounds show the best binding affinity: Sorbitol, Mannitol and Galactitol. To understand the perfect binding orientation and the strength of non-bonded interactions, individual molecular docking studies were perform for the best hits. Further molecular dynamics studies were conduct to analyze the efficacy between the protein–ligand complexes and it was identify that Sorbitol obtains the highest efficacy. The best-screened compounds obtained drug-like property and were less toxic, which could be use as a potential lead compound to develop anti-Ebola drugs.

Original languageEnglish
Pages (from-to)3315-3324
Number of pages10
JournalMolecular Biology Reports
Volume46
Issue number3
DOIs
Publication statusPublished - Jun 1 2019
Externally publishedYes

Fingerprint

Viral Matrix Proteins
Sugar Alcohols
Ebolavirus
Computer Simulation
Sorbitol
Galactitol
Pharmaceutical Preparations
Virus Release
Poisons
Mannitol
Virus Diseases
Molecular Dynamics Simulation
Antiviral Agents
Fever
RNA
Growth
Ebola virus nucleoprotein VP40

Keywords

  • Ebola
  • Molecular docking
  • Molecular dynamics simulations
  • Sugar alcohols
  • VP40

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus. / Nagarajan, Nagasundaram; Yapp, Edward K.Y.; Le, Nguyen Quoc Khanh; Yeh, Hui Yuan.

In: Molecular Biology Reports, Vol. 46, No. 3, 01.06.2019, p. 3315-3324.

Research output: Contribution to journalArticle

Nagarajan, Nagasundaram ; Yapp, Edward K.Y. ; Le, Nguyen Quoc Khanh ; Yeh, Hui Yuan. / In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus. In: Molecular Biology Reports. 2019 ; Vol. 46, No. 3. pp. 3315-3324.
@article{37ba687534304cf6a068d8ae13dabe7e,
title = "In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus",
abstract = "Ebola virus is a virulent pathogen that causes highly lethal hemorrhagic fever in human and non-human species. The rapid growth of this virus infection has made the scenario increasingly complicated to control the disease. Receptor viral matrix protein (VP40) is highly responsible for the replication and budding of progeny virus. The binding of RNA to VP40 could be the crucial factor for the successful lifecycle of the Ebola virus. In this study, we aimed to identify the potential drug that could inhibit VP40. Sugar alcohols were enrich with antiviral properties used to inhibit VP40. Virtual screening analysis was perform for the 48 sugar alcohol compounds, of which the following three compounds show the best binding affinity: Sorbitol, Mannitol and Galactitol. To understand the perfect binding orientation and the strength of non-bonded interactions, individual molecular docking studies were perform for the best hits. Further molecular dynamics studies were conduct to analyze the efficacy between the protein–ligand complexes and it was identify that Sorbitol obtains the highest efficacy. The best-screened compounds obtained drug-like property and were less toxic, which could be use as a potential lead compound to develop anti-Ebola drugs.",
keywords = "Ebola, Molecular docking, Molecular dynamics simulations, Sugar alcohols, VP40",
author = "Nagasundaram Nagarajan and Yapp, {Edward K.Y.} and Le, {Nguyen Quoc Khanh} and Yeh, {Hui Yuan}",
year = "2019",
month = "6",
day = "1",
doi = "10.1007/s11033-019-04792-w",
language = "English",
volume = "46",
pages = "3315--3324",
journal = "Molecular Biology Reports",
issn = "0301-4851",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus

AU - Nagarajan, Nagasundaram

AU - Yapp, Edward K.Y.

AU - Le, Nguyen Quoc Khanh

AU - Yeh, Hui Yuan

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Ebola virus is a virulent pathogen that causes highly lethal hemorrhagic fever in human and non-human species. The rapid growth of this virus infection has made the scenario increasingly complicated to control the disease. Receptor viral matrix protein (VP40) is highly responsible for the replication and budding of progeny virus. The binding of RNA to VP40 could be the crucial factor for the successful lifecycle of the Ebola virus. In this study, we aimed to identify the potential drug that could inhibit VP40. Sugar alcohols were enrich with antiviral properties used to inhibit VP40. Virtual screening analysis was perform for the 48 sugar alcohol compounds, of which the following three compounds show the best binding affinity: Sorbitol, Mannitol and Galactitol. To understand the perfect binding orientation and the strength of non-bonded interactions, individual molecular docking studies were perform for the best hits. Further molecular dynamics studies were conduct to analyze the efficacy between the protein–ligand complexes and it was identify that Sorbitol obtains the highest efficacy. The best-screened compounds obtained drug-like property and were less toxic, which could be use as a potential lead compound to develop anti-Ebola drugs.

AB - Ebola virus is a virulent pathogen that causes highly lethal hemorrhagic fever in human and non-human species. The rapid growth of this virus infection has made the scenario increasingly complicated to control the disease. Receptor viral matrix protein (VP40) is highly responsible for the replication and budding of progeny virus. The binding of RNA to VP40 could be the crucial factor for the successful lifecycle of the Ebola virus. In this study, we aimed to identify the potential drug that could inhibit VP40. Sugar alcohols were enrich with antiviral properties used to inhibit VP40. Virtual screening analysis was perform for the 48 sugar alcohol compounds, of which the following three compounds show the best binding affinity: Sorbitol, Mannitol and Galactitol. To understand the perfect binding orientation and the strength of non-bonded interactions, individual molecular docking studies were perform for the best hits. Further molecular dynamics studies were conduct to analyze the efficacy between the protein–ligand complexes and it was identify that Sorbitol obtains the highest efficacy. The best-screened compounds obtained drug-like property and were less toxic, which could be use as a potential lead compound to develop anti-Ebola drugs.

KW - Ebola

KW - Molecular docking

KW - Molecular dynamics simulations

KW - Sugar alcohols

KW - VP40

UR - http://www.scopus.com/inward/record.url?scp=85064353382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064353382&partnerID=8YFLogxK

U2 - 10.1007/s11033-019-04792-w

DO - 10.1007/s11033-019-04792-w

M3 - Article

C2 - 30982214

AN - SCOPUS:85064353382

VL - 46

SP - 3315

EP - 3324

JO - Molecular Biology Reports

JF - Molecular Biology Reports

SN - 0301-4851

IS - 3

ER -